Insights On Enterprise Solutions

  1. Strategies To Accelerate Gene Therapy Process Development 10/13/2026

    Gene therapy developers are accelerating timelines with platform approaches, DoE, stronger development-manufacturing alignment, and PAT tools to reach late-phase manufacturing faster.

  2. Advancing Parenteral Manufacturing: The Role Of The RTU Container 10/12/2026

    Presterilized vials, syringes, and cartridges reshaped aseptic fill-finish around small batches and multi-format lines. Regulatory fit, material choices, and high-speed filling will define where the technology goes next.

  3. Transitioning mRNA Production To cGMP Requires Early Process Engagement 10/9/2026

    Early choices in capping strategy, IVT conditions, raw materials, and downstream design shape yield, cost, and quality in mRNA manufacturing, and can determine whether a cGMP campaign succeeds.

  4. Optimizing GMP Manufacturing Of Lipid Nanoparticles For mRNA Encapsulation 10/9/2026

    Moving mRNA lipid nanoparticle encapsulation from pre-clinical work to cGMP production is often underestimated. Early process parameter definition, raw material control, and scalable mixing determine how low-risk that transition becomes.

  5. Discover Accelerated Approaches For Successful Commercial Filing 10/9/2026

    Early risk assessment, leaner scale-down model qualification, and tighter process characterization scope offer the clearest time savings in microbial filings, each with scientific trade-offs worth weighing.

  6. Developing Custom GMP Lipids: A Patient-Driven Partnership 10/8/2026

    Custom lipid programs depend on how process development and manufacturing teams collaborate, from first design through scale-up to GMP production for LNP-based therapies.

  7. Bridging Binder Discovery And Automated CAR T Cell Manufacturing 10/8/2026

    CLDN6-targeting CAR T cells for solid tumors move from binder discovery through manufacturing, with attention to how process design shapes technology transfer and consistency.

  8. An Automated Cell-Processing Platform For MSC Harvest 10/7/2026

    Discover closed, automated harvest, formulation, and dispensing of umbilical cord MSCs at commercial scale, with data on viability, recovery, and filling precision, including single runs.

  9. Smarter Lead Selection And Faster Representative Material 10/6/2026

    Accelerate biologics development with earlier high-titer material, reduced CMC risk, and faster lead selection using transposase-based vectors and stable bulk pools.

  10. Beyond Fed-Batch: Choosing The Right Path To Process Intensification 10/6/2026

    Upstream intensification options, from concentrated fed-batch to N-stage perfusion, are weighed against organizational objectives, since no single technical strategy suits every framework.